<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">Medical Scientific Bulletin of Central Chernozemye (Naučno-medicinskij vestnik Centralʹnogo Černozemʹâ)</journal-id><journal-title-group><journal-title>Medical Scientific Bulletin of Central Chernozemye (Naučno-medicinskij vestnik Centralʹnogo Černozemʹâ)</journal-title></journal-title-group><issn publication-format="electronic">1990-472X</issn><publisher><publisher-name>Федеральное государственное бюджетное образовательное учреждение высшего образования "Воронежский государственный медицинский университет имени Н.Н. Бурденко" Министерства здравоохранения Российской Федерации</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">7842</article-id><article-id pub-id-type="doi">10.18499/1990-472X-2022-0-88-93-102</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>ANTIVIRAL ANTIBODIES AND IMMUNE STATUS OF PATIENTS WITH ANXIETY-DEPRESSIVE DISORDERS</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Zemskov</surname><given-names>A. M</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bakulina</surname><given-names>N. I</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shiryaev</surname><given-names>O. Yu</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Peleshenko</surname><given-names>E. I</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kostenko</surname><given-names>S. M</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zemskova</surname><given-names>V. A</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff id="aff-1"></aff><pub-date date-type="epub" iso-8601-date="2022-09-28" publication-format="electronic"><day>28</day><month>09</month><year>2022</year></pub-date><issue>88</issue><fpage>93</fpage><lpage>102</lpage><history><pub-date date-type="received" iso-8601-date="2022-09-27"><day>27</day><month>09</month><year>2022</year></pub-date></history><permissions><copyright-statement>Copyright © 2022, Medical Scientific Bulletin of Central Chernozemye (Naučno-medicinskij vestnik Centralʹnogo Černozemʹâ)</copyright-statement><copyright-year>2022</copyright-year></permissions><abstract>A study was performed on the presence of antibodies against Epstein-Barr viruses, herpes simplex, cytomegalovirus in persons suffering from anxiety-depressive disorders. Pronounced changes in immunological parameters in this contingent from the level of practically healthy volunteers are shown. The dependence of quantitative and qualitative variations of immunological indicators, their correlation relationships on the type of carrying antiviral antibodies by patients has been established. It has been established that in patients with anxiety-depressive disorders, the carriage of antiviral antibodies against EBV occurs in each of the patients we studied, the combination of EBV, HSV and CMV antibodies is 70.5%, the combination of antibodies to EBV and HSV in 85.3% of cases, the combination of antibodies to EBV and CMV in 82.4% of cases.</abstract><kwd-group xml:lang="en"><kwd>anxiety-depressive disorders</kwd><kwd>viruses</kwd><kwd>antibodies</kwd><kwd>immunological disorders</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>тревожно-депрессивные расстройства</kwd><kwd>вирусы</kwd><kwd>антитела</kwd><kwd>иммунологические расстройства</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Земсков А.М., Есауленко И.Э. Курс лекций по клинической иммунофизиологии. Воронеж. Изд. Ритм, 2017. - 1048 с. @@Zemskov AM, Esaulenko I.E. Course of lectures on clinical immunophysiology. Voronezh. Ed. Rhythm, 2017. - 1048 s.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Земсков А.М., Земсков В.М Клиническая иммунология, под ред. профессора А.М.Земскова. Издательство «ГЭОТАРМедиа», 2008. - 426 с. @@Zemskov A.M., Zemskov V.M. Clinical immunology, ed. Professor A.M. Zemskov. publishing house "GEOTARMyeda," 2008. - 426 s.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Карауш И.С., Куприянова И.Е. Ранние дезадаптивные схемы как модераторы стресса и формирующейся психической патологии // Сибирский психологический журнал, № 83, 2022. - С. 122-140. @@Karaush I.S., Kupriyanova I.E. Early maladaptive schemes as moderators of stress and emerging mental pathology//Siberian Psychological Journal, No. 83, 2022. - S. 122-140.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Коморбидность тревожно-депрессивных расстройств и общесоматической патологии / И. В. Дубатова, С. В. Лепявка, А. В. Сафроненко [и др.] // Главный врач Юга России. - 2019. - № 4(68). - С. 52-55. @@Comorbidity of anxiety-depressive disorders and general somatic pathology/I.V. Dubatova, S.V. Lepyavka, A.V. Safronenko [and others ]//Chief Physician of the South of Rus. - 2019. - № 4. - S. 52-55.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Мамаев А.Н., Кудлай Д.А. Статистические методы в медицине. М.:Практическая медицина, 2021 г. - 136 с. @@Mamaev A.N., Kudlai D.A. Statistical methods in medicine. M.: Practical med., 2021 - 136 p.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Трухачева Н.В. Медицинская статистика. Учебное пособие. - М.:Феникс, 2017 8г. - 324 с. @@Trukhacheva N.V. Medical statistics. Tutorial. - M.: Phoenix, 2017 8g. - 324 s.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Broadley J., Perra F., Morrov G. et all. Expansions of Citotoxic CD4+CD28- T cells Fdrive Excesc Cardiovascular Mortality in Reumatoid Arthritis and other Chronic Inflammatory condition and Are Triggered by CMV infection. Frontiers in Immunology. 2017, vol. 8. Aricie 196.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Collora JA, Liu R, Pinto-Santini D, Ravindra N, Ganoza C, Lama JR, Alfaro R, Chiarella J, Spudich S, Mounzer K, Tebas P, Montaner LJ, van Dijk D, Duerr A, Ho YC. Single-cell multiomics reveals persistence of HIV-1 in expanded cytotoxic T cell clones. Immunity. 2022 Jun 14;55(6):1013-1031.e7. doi: 10.1016/j.immuni.2022.03.004. Epub 2022 Mar 22. PMID: 35320704; PMCID: PMC9203927.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Fu Fend, Vanjun L. Guihuan L. et all. Human CD8+CD28 - T Supressor Cells Expanded be IL15 in vitro Supress in an Allospecific and Programmed cell Deaty Protein 1. Dependent manner. Frontiers in Immunology, 2018. vol. 9. Aricie 1442.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Ga Hye Lee, Won Woo Lee. Unusual CD4+CD28- T cells and Their Patogenic Role in Chronic Inflammatory Discorder. Immune Net work. vol. 16. № 6. 2016. 322329.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Ganly L. Adriana T.L., Roby T.D. et all. Skinresident effector memory CD8+CD28 - T cells exhibit a projibrotic in patient with systemic sclerosis. J.Invest Dermatol. 2017. May; 137(5):10421050.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Wongwiwat W, Fournier B, Bassano I, Bayoumy A, Elgueta Karstegl C, Styles C, Bridges R, Lenoir C, BoutBoul D, Moshous D, Neven B, Kanda T, Morgan RG, White RE, Latour S, Farrell PJ. Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases. J Virol. 2022 Jun 22;96(12):e0039422. doi: 10.1128/jvi.00394-22. Epub 2022 May 25. PMID: 35612313; PMCID: PMC9215254.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Yamagishi M, Kubokawa M, Kuze Y, Suzuki A, Yokomizo A, Kobayashi S, Nakashima M, Makiyama J, Iwanaga M, Fukuda T, Watanabe T, Suzuki Y, Uchimaru K. Chronological genome and single-cell transcriptome integration characterizes the evolutionary process of adult T cell leukemia-lymphoma. Nat Commun. 2021 Aug 10;12(1):4821. doi: 10.1038/s41467-021-25101-9. PMID: 34376672; PMCID: PMC8355240.</mixed-citation></ref></ref-list></back></article>
